...
首页> 外文期刊>Bali Medical Journal >Coronavirus disease 2019 (COVID-19) A case report in a patient with diabetic ketoacidosis and hypertension
【24h】

Coronavirus disease 2019 (COVID-19) A case report in a patient with diabetic ketoacidosis and hypertension

机译:2019年(Covid-19)冠状病毒疾病(Covid-19)患者患有糖尿病酮症病毒和高血压的病例报告

获取原文

摘要

Background : Until May 2020, Indonesia is still on COVID-19 emergency status. South Jakarta is part of the Special Capital Region of Jakarta that has applied large-scale social restrictions. The Indonesian government has extended Jakarta's large-scale social restrictions to Friday, May 22~(nd), 2020 to curb the spread of the corona-virus that causes COVID-19. Case report : Patients with diabetic ketoacidosis and hypertension were infected with SARS-CoV-2. He had traveled from Saudi Arabia a week before and already has a fever. Arriving in Indonesia, the patient showed symptoms of worsening disease, experienced coughing, shortness of breath, and sore throat. The patient does not inject insulin due to loss of appetite. On March 30~(th), 2020, a laboratory examination showed high blood sugar levels (369 mg/dL) followed by positive ketones bodies. On April 2~(nd), 2020, the patient was designated as a confirmed case of COVID-19 after a positive polymerase chain reaction test. The rapid diagnostic test also showed a positive IgM.? Management of patient includes giving O_(2) through the non-rebreathing oxygen mask, infusion of sodium chloride, 20 IU Apidra?, 12 IU Lantus? injection, Oseltamivir orally, Levofloxacin, Paracetamol, Vitamin C, Candesartan, Concor. This therapy was continued until April 5~(th), 2020. On April 5~(th), the patient complained about a cold sensation all over his body. The patient died on the afternoon of April 6~(th), (8 days of hospitalization) due to sudden cardiac arrest and acute respiratory distress syndrome. Cardiopulmonary resuscitation was done with standardized protocol with no avail. Conclusion : Diabetic ketoacidosis and hypertension worsen the condition of COVID-19 patients. There are many unknown disease progression outcomes in these patients.
机译:背景:直到2020年5月,印度尼西亚仍在Covid-19紧急状态。南雅加达是雅加达特别首都地区的一部分,已经应用了大规模的社会限制。印度尼西亚政府将雅加达的大规模社会限制延长至周五,5月22日〜(ND),2020年,遏制导致Covid-19的电晕病毒的传播。案例报告:糖尿病酮症患者和高血压患者用SARS-COV-2感染。他一周前从沙特阿拉伯旅行,已经发烧了。抵达印度尼西亚,患者显示疾病恶化的症状,经历咳嗽,呼吸急促和喉咙痛。由于食欲丧失,患者不会注入胰岛素。在3月30日〜(Th),2020年,实验室检查显示出高血糖水平(369mg / dl),然后是阳性酮体。 4月2日〜(ND),2020,患者被指定为在阳性聚合酶链反应试验后作为Covid-19的确认情况。快速诊断测试也显示出阳性IgM。患者的管理包括通过非再灌注氧掩模给予O_(2),输注氯化钠,20 IU Apidraα,1,12IU·兰花?注射,Oseltamivir口服,左氧氟沙星,扑热息痛,维生素C,Candesartan,Concor。这种治疗持续到4月5日〜(Th),2020年。4月5日〜(Th),患者抱怨他的身体过度感冒。由于心脏骤停和急性呼吸窘迫综合征,患者在4月6日〜(Th)下午(住院治疗8天)死亡。用标准化的协议进行了心肺复苏,无济于事。结论:糖尿病酮症症和高血压恶化了Covid-19患者的状况。这些患者中有许多未知的疾病进展结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号